Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth.
Saved in:
| Title: | Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth. |
|---|---|
| Authors: | Zhang R; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Chen L; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Liang X; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Zhang J; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Hamamoto K; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Hattori T; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Vangala V; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Schell TD; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Saulnier Sholler G; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Takahashi Y; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA. ytakahashi@pennstatehealth.psu.edu.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA. ytakahashi@pennstatehealth.psu.edu., Wang HG; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA. huw11@psu.edu.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA. huw11@psu.edu. |
| Source: | Oncogene [Oncogene] 2026 Jun; Vol. 45 (23), pp. 2211-2224. Date of Electronic Publication: 2026 Apr 24. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8711562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5594 (Electronic) Linking ISSN: 09509232 NLM ISO Abbreviation: Oncogene Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42032367 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Zhang+R%22">Zhang R</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Liang+X%22">Liang X</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+J%22">Zhang J</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hamamoto+K%22">Hamamoto K</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Hattori+T%22">Hattori T</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Vangala+V%22">Vangala V</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Schell+TD%22">Schell TD</searchLink>; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Saulnier+Sholler+G%22">Saulnier Sholler G</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA.<br /><searchLink fieldCode="AU" term="%22Takahashi+Y%22">Takahashi Y</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA. ytakahashi@pennstatehealth.psu.edu.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA. ytakahashi@pennstatehealth.psu.edu.<br /><searchLink fieldCode="AU" term="%22Wang+HG%22">Wang HG</searchLink>; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA. huw11@psu.edu.; Department of Cell and Biological Systems, The Pennsylvania State University College of Medicine, Hershey, PA, USA. huw11@psu.edu. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228711562%22">Oncogene</searchLink> [Oncogene] 2026 Jun; Vol. 45 (23), pp. 2211-2224. <i>Date of Electronic Publication: </i>2026 Apr 24. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8711562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5594 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209509232%22">09509232 </searchLink><i>NLM ISO Abbreviation: </i>Oncogene <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42032367 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41388-026-03800-1 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 2211 Titles: – TitleFull: Targeting VPS4 elicits STING-driven anti-tumor immunity to suppress rhabdomyosarcoma growth. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Zhang R – PersonEntity: Name: NameFull: Chen L – PersonEntity: Name: NameFull: Liang X – PersonEntity: Name: NameFull: Zhang J – PersonEntity: Name: NameFull: Hamamoto K – PersonEntity: Name: NameFull: Hattori T – PersonEntity: Name: NameFull: Vangala V – PersonEntity: Name: NameFull: Schell TD – PersonEntity: Name: NameFull: Saulnier Sholler G – PersonEntity: Name: NameFull: Takahashi Y – PersonEntity: Name: NameFull: Wang HG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2026 Jun Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5594 Numbering: – Type: volume Value: 45 – Type: issue Value: 23 Titles: – TitleFull: Oncogene Type: main |
| ResultId | 1 |